trial · primary record
Bupropion Hydrochloride 150 MG
End Stage Renal Disease
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2028-05 |
| Primary endpoint | Change in Brief Fatigue Inventory (BFI) Global Score |
| Registry ID | NCT06609343 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:56.312Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06609343
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.